Expression of CD147 after neoadjuvant chemotherapy and its relationship with prognosis in patients with triple negative breast cancer
CONCLUSION: CD147 can promote the proliferation and invasion of breast cancer cells, which underlines its value in the diagnosis and treatment of TNBC.PMID:35702119 | PMC:PMC9185091
Source: American Journal of Translational Research - Category: Research Authors: Wei Zhang Hui Liu Junjie Jiang Yunyun Yang Wenjie Wang Zhengyan Jia Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research